TMEM167B: A Potential Drug Target in Neurodegenerative Disorders and Other Diseases

Target Name: TMEM167B

NCBI ID: G56900

TMEM167B

TMEM167B: A Potential Drug Target in Neurodegenerative Disorders and Other Diseases

TMEM167B (AD-020) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the transmembrane protein family, which means that it is synthesized and stored within the cell membrane, and it functions as a receptor for various molecules, including drugs and toxins.

TMEM167B has been identified as a potential drug target due to its involvement in a variety of cellular processes, including cell signaling, inflammation, and stress response. It is also expressed in various diseases, including neurodegenerative disorders, cardiovascular disease, and kidney disease.

One of the key features of TMEM167B is its ability to interact with various signaling molecules, including neurotransmitters and cytokines. This interaction allows it to play a role in cellular signaling pathways, including the regulation of neurotransmitter release, neuroinflammation, and stress response.

In addition to its potential role in signaling pathways, TMEM167B is also involved in the regulation of inflammation. It has been shown to play a role in the regulation of inflammatory cytokine production and the recruitment of immune cells to the site of inflammation.

TMEM167B is also involved in stress response, as it has been shown to be regulated by stress-induced signaling pathways. This regulation allows it to play a role in the regulation of cellular stress responses, including the regulation of apoptosis.

Another potential role of TMEM167B is its involvement in the regulation of cellular homeostasis. It is a member of the T-cell antigen 4 (TAG-4) family, which is involved in the regulation of cellular

Protein Name: Transmembrane Protein 167B

Functions: Involved in the early part of the secretory pathway

The "TMEM167B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM167B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets